Abstract
The catalytic asymmetric dihydroxylation (AD) discovered by Sharpless, a Nobel Prize winner in 2001, has rapidly become an invaluable synthetic tool in the possibility of converting prochiral olefins to chiral vicinal diols. After our long-running investigation of optimized methodology for the production of stereo-defined diols based on the AD reaction, an efficient and environmentally friendly approach for the synthesis of (S)-metoprolol via AD reaction was reported. The synthetic route proceeded in four-step reactions of nucleophilic substitution, AD reaction, cyclization, and nucleophilic ring opening. The key step, AD reaction, proceeded effectively in homogeneous catalysis by using a soluble polymer chiral ligand QN-AQN-OPEG-OMe, which can be easily separated from the reaction system and reused at least four times while maintaining its high catalytic activity and enantioselectivity. This protocol has been demonstrated to produce kilogram quantities of (S)-metoprolol on scale.
Keywords: Asymmetric dihydroxylation, asymmetric synthesis, polymer ligand, recoverable, (S)-metoprolol, biocatalysis, migraine, headaches, anxiety, beta-blocker
Letters in Organic Chemistry
Title:Asymmetric Synthesis of (S)-metoprolol via Sharpless Asymmetric Dihydroxylation Induced by A Recoverable Polymer Ligand QN-AQNOPEG- OMe
Volume: 9 Issue: 7
Author(s): Sikun Cheng, Xueying Liu, Pingan Wang, Xiaoye Li, Wei He and Shengyong Zhang
Affiliation:
Keywords: Asymmetric dihydroxylation, asymmetric synthesis, polymer ligand, recoverable, (S)-metoprolol, biocatalysis, migraine, headaches, anxiety, beta-blocker
Abstract: The catalytic asymmetric dihydroxylation (AD) discovered by Sharpless, a Nobel Prize winner in 2001, has rapidly become an invaluable synthetic tool in the possibility of converting prochiral olefins to chiral vicinal diols. After our long-running investigation of optimized methodology for the production of stereo-defined diols based on the AD reaction, an efficient and environmentally friendly approach for the synthesis of (S)-metoprolol via AD reaction was reported. The synthetic route proceeded in four-step reactions of nucleophilic substitution, AD reaction, cyclization, and nucleophilic ring opening. The key step, AD reaction, proceeded effectively in homogeneous catalysis by using a soluble polymer chiral ligand QN-AQN-OPEG-OMe, which can be easily separated from the reaction system and reused at least four times while maintaining its high catalytic activity and enantioselectivity. This protocol has been demonstrated to produce kilogram quantities of (S)-metoprolol on scale.
Export Options
About this article
Cite this article as:
Cheng Sikun, Liu Xueying, Wang Pingan, Li Xiaoye, He Wei and Zhang Shengyong, Asymmetric Synthesis of (S)-metoprolol via Sharpless Asymmetric Dihydroxylation Induced by A Recoverable Polymer Ligand QN-AQNOPEG- OMe, Letters in Organic Chemistry 2012; 9 (7) . https://dx.doi.org/10.2174/157017812802139645
DOI https://dx.doi.org/10.2174/157017812802139645 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Genetics of Bladder Malignant Tumors in Childhood
Current Genomics Can Lipoprotein-associated Phospholipase A<sub>2</sub> be Used as a Predictor of Long-term Outcome in Patients with Acute Coronary Syndrome?
Current Cardiology Reviews In Vivo Roles of CDC25 Phosphatases: Biological Insight into the Anti-Cancer Therapeutic Targets
Anti-Cancer Agents in Medicinal Chemistry Transforming Growth Factor-Beta and the Kidney: What We Know and What We Can Do?
Current Enzyme Inhibition The Cellular and Molecular Basis of Health Benefits of Grape Seed Proanthocyanidin Extract
Current Pharmaceutical Biotechnology Central Blood Pressure and End-organ Damage
Current Hypertension Reviews C-glycosyl Flavone from Urginea indica Inhibits Growth and Dissemination of Ehrlich Ascites Carcinoma Cells in Mice
Anti-Cancer Agents in Medicinal Chemistry Beta-Blocker Therapy for Septic Cardiac Shock: Fiction Or Realism?
Current Drug Therapy Pharmacology and Therapeutic Applications of A3 Receptor Subtype
Current Topics in Medicinal Chemistry What Does a Pediatrician Need to Know About Chronic Diarrhea?
Current Pediatric Reviews Hypoxia in DU-145 Prostate Cancer Xenografts after Estramustine Phosphate and Radiotherapy
Current Radiopharmaceuticals ACE2 as a Key Target for Treatment of COVID-19 Related Cardiovascular Diseases: Current Progress and Prospect
Current Drug Targets Obstructive Sleep Apnea and Type 2 Diabetes: Dual Interaction
Current Respiratory Medicine Reviews Outcomes with Dronedarone in Atrial Fibrillation: What Differences Between Real-World Practice and Trials? A Meta-Analysis and Meta-Regression Analysis
Current Pharmaceutical Design The Role of STAT 3 in Tissue Fibrosis
Current Chemical Biology The Antagonists of Endothelin Receptors: Results and Perspectives
Current Pharmaceutical Analysis Carotid Baroreceptor Stimulation: A Promising Approach for the Management of Resistant Hypertension and Heart Failure
Current Vascular Pharmacology Pharmacological Properties and Therapeutic Possibilities for Drugs Acting Upon Endocannabinoid Receptors
Current Drug Targets - CNS & Neurological Disorders Macromolecular Drug Targets in Cancer Treatment and Thiosemicarbazides as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Crocetin: an Agent Derived from Saffron for Prevention and Therapy for Cancer
Current Pharmaceutical Biotechnology